BioSpace News Archive

Lone Star Bio

Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement

Lexicon Pharmaceuticals, Inc. announced the pricing of its previously announced underwritten public offering of 23,924,705 shares of its common stock, par value $0.001.

June 1, 2023
·
6 min read
Pharm Country

Elevar Therapeutics to Participate in ASCO 2023 and BIO 2023; New Jersey-based Company Secures State License as It Builds Toward Commercialization

Elevar Therapeutics, Inc. announced its participation plans for the 2023 American Society of Clinical Oncology Annual Meeting in Chicago and the 2023 BIO International Convention in Boston.

June 1, 2023
·
7 min read
Genetown

Ocean Biomedical (NASDAQ: OCEA) Announces Initiation of Coverage by Taglich Brothers with a Share Price Target of $20.

Ocean Biomedical, Inc. announced that an equity analyst coverage report has been issued by Taglich Brothers with a price target of $20 per share.

June 1, 2023
·
7 min read
Biotech Beach

Poseida Therapeutics Announces Virtual 2023 Annual Meeting of Stockholders

Poseida Therapeutics, Inc. today announced that its virtual Annual Meeting of Stockholders (the “Annual Meeting”) will be held on Thursday, June 15, 2023 at 1:00 p.m. PT.

June 1, 2023
·
2 min read
Business

Galmed Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Developments

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical company for liver and fibro-inflammatory diseases reports financial results for the three months ended March 31, 2023 and recent developments

June 1, 2023
·
8 min read
Biotech Bay

Rigel Announces Poster Presentation at the Upcoming 2023 American Society of Clinical Oncology Annual Meeting

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced an upcoming poster presentation highlighting the Company’s IRAK1/4 program at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting being held June 2-6, 2023, in Chicago, IL , and virtually.

June 1, 2023
·
4 min read
Drug Development

Clarametyx Announces Positive Early Phase 1 Safety Findings on CMTX-101, Immune-Enabling Antibody Therapy

Clarametyx Biosciences, Inc . today announced positive initial safety data from the Phase 1a portion of its clinical development program for CMTX-101, a novel immune-enabling antibody therapy designed to treat serious bacterial infections, with no safety concerns identified.

June 1, 2023
·
2 min read
BioMidwest

Sarah Cannon Research Institute to Present Latest Oncology Research Insights at 2023 ASCO® Annual Meeting

Sarah Cannon Research Institute announced that its network of research leaders have been selected to deliver insights through more than 135 abstracts and presentations at the 2023 American Society of Clinical Oncology Annual Meeting June 2-6, 2023.

June 1, 2023
·
6 min read
Pharm Country

Laxxon Medical to Participate in 2023 BIO International Convention

Laxxon Medical announced today its participation in the 2023 BIO International Convention.

June 1, 2023
·
1 min read
Business

National Kidney Foundation Appoints Walmart Chief Medical Officer Dr. Wigneswaran to National Board of Directors

The National Kidney Foundation is thrilled to announce the appointment of Dr. John Wigneswaran, Walmart’s Chief Medical Officer, to NKF’s National Board of Directors.

June 1, 2023
·
3 min read